Latest Biotechnology, Pharmaceutical and Healthcare News

07:16 EST 20th December 2014 | BioPortfolio

Showing News Articles 1–25 of 730,000+

Saturday 20th December 2014

Risperdal Lawsuit News: Bernstein Liebhard LLP Notes Publication of Study Suggesting Medication May Raise Prolactin Levels in Children

The Firm is representing numerous men and boys in Risperdal lawsuits, all of whom allegedly developed gynecomastia (male breast growth) due to an elevation of prolactin caused by Risperdal. New York, New York (PRWEB) December 20, 2014 As Risperdal lawsuits (http://www.risperdallawsuit2014.com/) continue to move forward in U.S. courts, Bernstein Liebhard LLP notes the publication of a new study w...

24 Hour Fitness to Acquire 32 Bally Clubs

Brand Position in San Francisco Bay Area, Colorado and New York City Area Strengthened By Acquisition 24 Hour Fitness USA, Inc. announced that it has acquired 32 fitness clubs from Bally Total Fitness, including clubs located in New York, New Jersey, Denver and the San Francisco Bay Area. The transaction closed on December 19, 2014. This is the first a...

Siemens won't float healthcare unit in 2015 - Wirtschafts Woche

FRANKFURT, Dec 20 (Reuters) - Siemens has no plans to float its healthcare business next year following the legal separation of the unit in countries including Germany, Chief Executive Joe Kaeser told the weekly publication Wirtschafts Woche.

50,000 Online Therapists Prepare to Treat Holiday Depression; eTherapi Telemedicine Removes Obstacles to Care

More than 50,000 therapists are preparing to treat the increase in depression that occurs during the holidays. They are part of eTherapi, telemedicine that allows patients to have remote therapy sessions through a secure, online video connection. San Francisco, California (PRWEB) December 20, 2014 More than 50,000 therapists have joined eTherapi, the nation’s largest online therapy service, and...

Paul Battaglia, DC Unveils Brand New Website to Offer Better Access for Patients

North Woods Chiropractic in Hayden, Idaho offers patients and prospects a better online experience and new ways to connect with the practice. The new website puts a greater focus on patient education with plenty of information on services. Hayden, Idaho (PRWEB) December 20, 2014 Dr. Paul Battaglia has provided his approach to chiropractic service to thousands of patients, for many years. Like his...

Lasso Injury Law Wishes you a Happy─and Safe─Holiday Season

Las Vegas Personal Injury Attorney Al Lasso reminds everyone to prioritize safety this holiday season. By being responsible, planning ahead, and keeping a close eye on kids, the season can be safe and fun for everyone. Las Vegas, NV (PRWEB) December 20, 2014 "The most important reminder I can offer is to never drink and drive," Attorney Al Lasso of Lasso Injury Law says. "Of course...

Viekira OK'd; AbbVie prices under Gilead's Harvoni

Shares of AbbVie closed at $67.71 on 19 December, down 21 cents.

FDA defies advisers; OK's AZ's ovarian cancer drug Lynparza

Shares of AstraZeneca closed at $71.69, down 42 cents.

BioNotebook: Ten deals and a breakup; Gilead/Ono, Vernalis/Novartis, Sorrento/NantWorks and more

Gilead licenses Ono BTK Inhibitor; Novartis stops developing Vernalis drug; Sorrento partners with NantWorks, Conkwest; Xencor, Novo enter discovery collaboration; ContraVir licenses Chimerix antiviral; MiNa accesses Marina technology; Bayer takes se...

Friday 19th December 2014

American nurse exposed to Ebola released from hospital

(Reuters) - An American nurse who was exposed to Ebola while volunteering in Sierra Leone was released from the National Institutes of Health's Clinical Center in Maryland on Friday without showing signs of the disease, NIH said.

Cubist wins FDA nod for antibiotic Zerbaxa

Shares of Cubist rose $2.08, or 2.1%, in after-hours trading on 19 December.

ASAlaser 2014: Between Positive Budget and New Projects

Vicenza, Italy, December 20, 2014 --(PR.com)-- ASAlaser’s 2014 closed with a positive sign. The company, despite the complex economic situation, initials new successes also for the current year, marked by not only an increase in sales and the consolidation of the European market, but also by the opening of new distribution channels for the Human and Vet sector. ASAlaser’s devices for ...

Ethan Jostad Foundation Gives Gift of Childhood Cancer Research

Eagle Point, OR, December 20, 2014 --(PR.com)-- The Ethan Jostad Foundation for Childhood Cancer, a 501c3 non-profit charity dedicated to providing support to the children and families affected by childhood cancer, announced today that it's Board of Directors has approved a donation in the amount of $10,000 to the Children's Cancer Therapy Development Institute (cc-TDI for short). The don...

Marketresearchreports.biz: Global Vanadium Usage Increased at AAGR of 6.7% between 2001 and 2013

Marketresearchreports.biz has included a new research report based on the global as well as Chinese market of vanadium, titled “Global and China Vanadium Industry Report 2014-2017,” to its huge collection of market research reports. Albany, NY (PRWEB) December 20, 2014 These vanadium reserves are mostly found in China, South Africa, Russia, and other nations. Around 151,000 tons of vanadium w...

Weijian Pharma to Market Infertility Drug in China for LG Lifesciences

China's Weijian Pharma Group obtained China marketing rights to an infertility treatment produced by LG Lifesciences of Korea. The treatment is Follitrope, an ovulation induction product, which increases follicle stimulating hormone (FSH). LG Lifesci...

AMMS-CanSino to Start Clinical Trial of China Ebola Vaccine

A China-discovered Ebola vaccine, developed jointly by the Bioengineering Institute of China's Academy of Military Medical Sciences (AMMS) and Tianjin CanSino Biotechnology, has been approved to begin clinical trials. The Bioengineering Institute has...

FDA Approves Zerbaxa (ceftolozane/tazobactam) for Complicated Intra-Abdominal/Urinary Tract Infections

December 19, 2014 -- The U.S. Food and Drug Administration today approved Zerbaxa (ceftolozane/tazobactam), a new antibacterial drug product, to treat adults with complicated intra-abdominal infections (cIAI) and complicated urinary tract infections....

U.S. FDA approves AbbVie hepatitis C drug, costs $83,319 for 12 weeks

(Reuters) - U.S. health regulators on Friday approved AbbVie's all-oral treatment for hepatitis C, and the company said the drug would cost $83,319 for a typical 12-week plan, a bit below its huge selling competitor Solvadi from Gilead Sciences.

UPDATE 2-U.S. FDA approves AbbVie hepatitis C drug, costs $83,319 for 12 weeks

Dec 19 (Reuters) - U.S. health regulators on Friday approved AbbVie's all-oral treatment for hepatitis C, and the company said the drug would cost $83,319 for a typical 12-week plan, a bit below its huge selling competitor Solvadi from Gilead Science...

U.N. chief praises Ebola nurses, pledges support during visit

HASTINGS, Sierra Leone (Reuters) - U.N. Secretary General Ban Ki-moon on Friday praised healthcare workers fighting the Ebola virus as he paid his first visit to Liberia and Sierra Leone following an outbreak that has killed nearly 7,000 people.

UPDATE 2-UN chief praises Ebola nurses, pledges support during visit

* Ebola death toll nears 7,000 (Recasts after Sierra Leone visit)

Roche kauft Bina Technologies

Basel (awp/sda/awp) - Roche kauft das auf Genanalyse spezialisierte Unternehmen Bina Technologies mit Sitz in Redwood City im US-Bundesstaat Kalifornien. Das teilte der Basler Pharmakonzern am Frei...

Accretive Health Provides Updated Timeline for Completion of Restatement

Expects to File 2013 Form 10-K and Hold Business Update Call on Dec. 30 Accretive Health, Inc. (OTC Pink: ACHI) today announced that it is in the final stages of completing its financial restatement. The Company currently expects to file its Annual Report on Form 10-K for the year ended December 31, 2013 with the Securities and Exchange Commission ...

Concerns raised about variable performance of some UK personal use breathalysers

  Ability of devices to detect potentially unsafe alcohol levels prompts questions about regulatory process The ability of some breathalysers widely sold to the UK public to detect potentially unsafe levels of breath alcohol for driving, varies considerably, reveals research published in BMJ Open. The findings call into question the regulatory process for approving these sorts […]

Food Safety Together

By: Mary Lou Valdez and Julie Moss Ph.D., R.D. In early December, we represented the FDA in Cape Town, South Africa, at the third annual conference of the Global Food Safety Partnership (GFSP). FDA has been a strong supporter of the … Continue reading →


Search BioPortfolio:
Loading
Advertisement
Advertisement

BioPortfolio's biotechnology, pharmaceutical, healthcare and medical device information service collates press releases, news articles and blogs from over 275 sources.